Urology | StoneDisease.org

Urology

Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation.

Chandhoke PS , Fan J , Yagisawa T.

Urology. 1998 Nov;52(5):750-5.

Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.

Cole FE , Erwin DT , Fuselier HA , Galliano DJ , Husserl FE , Kok DJ , Lindberg JS , Moore K , Whitehead D.

Urology. 1998 Dec;52(6):988-94

Read more

Partial dissolution of struvite calculus with oral acetohydroxamic acid.

Peterson CM , Rodman JS , Williams JJ.

Urology. 1983 Oct;22(4):410-2

Low urinary citrate excretion in nephrolithiasis.

Nicar MJ , Pak CY , Sakhaee K , Skurla C.

Urology. 1983 Jan;21(1):8-14.

Read more

Urinary excretion of oxalate by patients with renal hypercalciuric stone disease. Effect of chronic treatment with hydrochlorothiazide.

Braverman S , Motola JA , Smith AD , Urivetzky M.

Urology. 1991 Apr;37(4):327-30.

Read more

Radiolucent renal stones in children: combined use of shock wave lithotripsy and dissolution therapy.

Abdeldaeim HM , Hashad MM , Mokhless IA , Sakr MA.

Urology. 2009 Apr;73(4):772-5. Epub 2009 Feb 4

Read more

Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.

Cullen J , Gancarczyk KK , Koff SG , Paquette EL , Schenkman NS , Tucciarone PR.

Urology. 2007 Jun;69(6):1013-6

Read more

The information contained in the professional section of the website is intended for health care professionals in the United States only. If you are not a US health care professional, please visit the StoneDisease.org patient website.